Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EICKEMEYER - MEDICINTEKNIK FOR DYRLÆGER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.3% 1.2% 1.1% 1.3% 1.1% 1.1% 7.3% 7.3%   Credit score (0-100)   82 82 83 79 84 84 33 33   Credit rating   A A A A A A BBB BBB   Credit limit (kDKK)   205.2 348.4 638.9 283.5 1,081.5 1,039.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,116 9,329 12,282 13,664 12,946 14,443 0.0 0.0   EBITDA   3,107 3,018 4,554 4,552 2,506 2,417 0.0 0.0   EBIT   3,008 2,777 4,289 4,234 2,157 2,099 0.0 0.0   Pre-tax profit (PTP)   3,041.3 2,875.9 4,199.6 4,127.9 2,282.0 2,119.5 0.0 0.0   Net earnings   2,363.8 2,224.1 3,276.6 3,223.6 1,775.3 1,641.4 0.0 0.0   Pre-tax profit without non-rec. items   3,041 2,876 4,200 4,128 2,282 2,120 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   4,423 5,555 5,537 5,597 5,501 5,557 0.0 0.0   Shareholders equity total   7,957 10,181 13,458 16,681 18,456 20,098 19,348 19,348   Interest-bearing liabilities   2,417 2,277 1,948 1,846 1,796 1,743 0.0 0.0   Balance sheet total (assets)   14,328 18,382 20,498 23,080 24,462 25,925 19,348 19,348   Net Debt   312 -814 669 -1,173 -1,969 -1,959 -19,348 -19,348     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,116 9,329 12,282 13,664 12,946 14,443 0.0 0.0   Gross profit growth   61.7% 2.3% 31.7% 11.2% -5.2% 11.6% -100.0% 0.0%   Employees   9 11 14 17 19 21 0 0   Employee growth %   12.5% 22.2% 27.3% 21.4% 11.8% 10.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,328 18,382 20,498 23,080 24,462 25,925 19,348 19,348   Balance sheet change%   76.7% 28.3% 11.5% 12.6% 6.0% 6.0% -25.4% 0.0%   Added value   3,107.4 3,017.6 4,554.0 4,551.9 2,474.9 2,416.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,916 891 -283 -257 -445 -262 -5,557 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.0% 29.8% 34.9% 31.0% 16.7% 14.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   27.8% 18.2% 22.2% 19.4% 9.9% 8.8% 0.0% 0.0%   ROI %   38.0% 26.0% 30.9% 24.9% 12.1% 10.5% 0.0% 0.0%   ROE %   34.9% 24.5% 27.7% 21.4% 10.1% 8.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   55.5% 55.4% 65.7% 72.3% 75.4% 77.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   10.0% -27.0% 14.7% -25.8% -78.6% -81.0% 0.0% 0.0%   Gearing %   30.4% 22.4% 14.5% 11.1% 9.7% 8.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.7% 4.3% 5.5% 5.6% 4.4% 6.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.4 1.4 1.8 2.2 2.4 2.2 0.0 0.0   Current Ratio   2.3 2.1 2.9 3.8 4.4 4.9 0.0 0.0   Cash and cash equivalent   2,105.0 3,091.2 1,278.7 3,019.4 3,765.8 3,701.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   5,562.5 6,618.5 9,810.9 12,890.3 14,659.6 16,187.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   345 274 325 268 130 115 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   345 274 325 268 132 115 0 0   EBIT / employee   334 252 306 249 114 100 0 0   Net earnings / employee   263 202 234 190 93 78 0 0